<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) are used as standard therapy to prevent <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>Today, physicians in emergency and intensive care medicine are often confronted with problems of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy in these patients </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a patient suffering from recurrent <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) requiring antiarrhythmia treatment with <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>With an increasing drug loading, the VT cycle length was progressively prolonged resulting in a slow VT undetectable for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, the patient was scheduled for VT ablation after which the patient became free of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> recurrences </plain></SENT>
</text></document>